Literature DB >> 24315195

Strategies for lead discovery: application of footprint similarity targeting HIVgp41.

Patrick M Holden1, William J Allen1, Miriam Gochin2, Robert C Rizzo3.   

Abstract

A highly-conserved binding pocket on HIVgp41 is an important target for development of anti-viral inhibitors. Holden et al. (Bioorg. Med. Chem. Lett.2012, 22, 3011) recently reported 7 experimentally-verified leads identified through a computational screen to the gp41 pocket in conjunction with a new DOCK scoring method (termed FPS scoring) developed in our laboratory. The method employs molecular footprints based on per-residue van der Waals interactions, electrostatic interactions, or the sum. In this work, we critically examine the gp41 screening results, prioritized using different scoring methods, in terms of two main criteria: (1) ligand pose properties which include footprint and energy score decompositions, MW, number of rotatable bonds, ligand efficiency, formal charge, and volume overlap, and (2) ligand pose stability which includes footprint stability (changes in footprint overlap) and rmsd stability (changes in geometry). Relative to standard DOCK scoring, pose property analyses demonstrate how FPS scoring can be used to identify ligands that mimic a known reference (derived here from the native gp41 substrate), while pose stability analyses demonstrate how FPS scoring can be used to enrich for compounds with greater overall stability during molecular dynamics (MD) simulations. Compellingly, of the 115 compounds tested experimentally, the 7 active compounds, as a group, more closely mimic the footprints made by the reference and show greater MD stability compared to the inactive group. Extensive studies using 116 protein-ligand complexes as controls reveal that ligands in their crystallographic binding pose also maintain higher FPS scores and smaller rmsds than do accompanying decoys, confirming that native poses are indeed 'stable' under the same conditions and that monitoring FPS variability during compound prioritization is likely to be beneficial. Overall, the results suggest the new scoring method will complement current virtual screening approaches for both the identification (FPS-ranking) and prioritization (FPS-stability) of target-compatible molecules in a quantitative and logical way.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DCE; DOCK; DOCK Cartesian energy; Docking; ES; FPS; Footprint similarity; HIV; MD; Molecular dynamics; Protein–protein interactions; SASA; Scoring functions; VDW; Virtual screening; electrostatic; footprint similarity; glycoprotein-41; gp41; molecular dynamics; solvent accessible surface area; van der Waals

Mesh:

Substances:

Year:  2013        PMID: 24315195      PMCID: PMC3913180          DOI: 10.1016/j.bmc.2013.10.022

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  40 in total

1.  Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.

Authors:  D M Eckert; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

3.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

Review 4.  Resistance to enfuvirtide, the first HIV fusion inhibitor.

Authors:  Michael L Greenberg; Nick Cammack
Journal:  J Antimicrob Chemother       Date:  2004-07-01       Impact factor: 5.790

5.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

6.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

7.  Potent D-peptide inhibitors of HIV-1 entry.

Authors:  Brett D Welch; Andrew P VanDemark; Annie Heroux; Christopher P Hill; Michael S Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-17       Impact factor: 11.205

8.  Grid-based molecular footprint comparison method for docking and de novo design: application to HIVgp41.

Authors:  Trent E Balius; William J Allen; Sudipto Mukherjee; Robert C Rizzo
Journal:  J Comput Chem       Date:  2013-02-22       Impact factor: 3.376

9.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

10.  A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Authors:  C Wild; T Oas; C McDanal; D Bolognesi; T Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  10 in total

1.  The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.

Authors:  Hao-Chi Hsu; Simon Tong; Yuchen Zhou; Matthew W Elmes; Su Yan; Martin Kaczocha; Dale G Deutsch; Robert C Rizzo; Iwao Ojima; Huilin Li
Journal:  Biochemistry       Date:  2017-06-28       Impact factor: 3.162

2.  Customizable de novo design strategies for DOCK: Application to HIVgp41 and other therapeutic targets.

Authors:  William J Allen; Brian C Fochtman; Trent E Balius; Robert C Rizzo
Journal:  J Comput Chem       Date:  2017-09-22       Impact factor: 3.376

3.  Structure-based identification of inhibitors targeting obstruction of the HIVgp41 N-heptad repeat trimer.

Authors:  T Dwight McGee; Hyun Ah Yi; William J Allen; Amy Jacobs; Robert C Rizzo
Journal:  Bioorg Med Chem Lett       Date:  2017-05-08       Impact factor: 2.823

4.  Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formation.

Authors:  William J Allen; Hyun Ah Yi; Miriam Gochin; Amy Jacobs; Robert C Rizzo
Journal:  Bioorg Med Chem Lett       Date:  2015-04-28       Impact factor: 2.823

5.  Implementation of the Hungarian algorithm to account for ligand symmetry and similarity in structure-based design.

Authors:  William J Allen; Robert C Rizzo
Journal:  J Chem Inf Model       Date:  2014-01-29       Impact factor: 4.956

6.  Identification of a Water-Coordinating HER2 Inhibitor by Virtual Screening Using Similarity-Based Scoring.

Authors:  Jiaye Guo; Stephen Collins; W Todd Miller; Robert C Rizzo
Journal:  Biochemistry       Date:  2018-07-30       Impact factor: 3.162

7.  Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry.

Authors:  Courtney D Singleton; Monica S Humby; Hyun Ah Yi; Robert C Rizzo; Amy Jacobs
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

8.  Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening.

Authors:  Yuchen Zhou; Matthew W Elmes; Joseph M Sweeney; Olivia M Joseph; Joyce Che; Hao-Chi Hsu; Huilin Li; Dale G Deutsch; Iwao Ojima; Martin Kaczocha; Robert C Rizzo
Journal:  Biochemistry       Date:  2019-10-11       Impact factor: 3.162

9.  Pharmacophore-based similarity scoring for DOCK.

Authors:  Lingling Jiang; Robert C Rizzo
Journal:  J Phys Chem B       Date:  2014-10-10       Impact factor: 2.991

10.  Identification of Zika Virus Inhibitors Using Homology Modeling and Similarity-Based Screening to Target Glycoprotein E.

Authors:  Stephen M Telehany; Monica S Humby; T Dwight McGee; Sean P Riley; Amy Jacobs; Robert C Rizzo
Journal:  Biochemistry       Date:  2020-09-17       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.